Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1 Multiple Pulmonary Nodules 1 Lung Neoplasms 1 Liver Neoplasms 1 Hemorrhage 1 Colorectal Neoplasms 1 Blood Loss, Surgical 1

Interventions

Oxaliplatin 270 Bevacizumab 260 Fluorouracil 249 Irinotecan 240 Leucovorin 218 Capecitabine 196 Cetuximab 161 Colonoscopy 74 Folfox protocol 70 Panitumumab 64 regorafenib 62 Drug Therapy 52 Radiotherapy 50 HMPL-013 50 Blood Specimen Collection 45 trifluridine tipiracil drug combination 43 pembrolizumab 41 Surveys and Questionnaires 35 Standard of Care 35 Nivolumab 34 Neoadjuvant Therapy 34 Surgical Procedures, Operative 33 Magnetic Resonance Spectroscopy 31 IFL protocol 27 Trifluridine 26 Interviews as Topic 26 Celecoxib 26 XELOX 25 Early Intervention, Educational 24 Specimen Handling 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Colorectal Neoplasms × Neuromuscular Blockade × Clear all

NCT02327494 2015-01-07

OXYMUBLOC

Hospital Universitari de Bellvitge

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡